Siemens Healthineers Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Siemens Healthineers (ETR:SHL) Second Quarter 2025 Results

Key Financial Results

• Revenue: €5.91b (up 8.7% from 2Q 2024).
• Net income: €530.0m (up 24% from 2Q 2024).
• Profit margin: 9.0% (up from 7.8% in 2Q 2024). The increase in margin was driven by higher revenue.
• EPS: €0.48 (up from €0.38 in 2Q 2024).

We've discovered 1 warning sign about Siemens Healthineers. View them for free.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Siemens Healthineers Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) missed analyst estimates by 4.8%.

Looking ahead, revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 5.8% growth forecast for the Medical Equipment industry in Germany.

Performance of the German Medical Equipment industry.

The company's shares are down 2.0% from a week ago.

Valuation

It's possible that Siemens Healthineers could be undervalued with our 6-factor valuation analysis indicating a potential opportunity. To explore our complete evaluation click here and get an understanding of what analysts are thinking about the company's future.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.